US Stock MarketDetailed Quotes

BBLG Bone Biologics

Watchlist
  • 2.1300
  • +0.0900+4.41%
Close Mar 28 16:00 ET
  • 2.2500
  • +0.1200+5.63%
Post 19:57 ET
1.87MMarket Cap-62P/E (TTM)

About Bone Biologics Company

Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.

Company Profile

SymbolBBLG
Company NameBone Biologics
Listing Date10/13/2021
Founded2004
CEOMr. Jeffrey Frelick
MarketNASDAQ
Employees2
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2 Burlington Woods Drive,Suite 100
CityBurlington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01803
Phone1-781-552-4452

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey Frelick
  • Chief Executive Officer and President
  • 414.72K
  • Deina H. Walsh
  • Chief Financial Officer and Principal Accounting Officer
  • 250.46K
  • Don Rufus Hankey
  • Chairman of the Board
  • --
  • Robert E. Gagnon
  • Independent Director
  • --
  • Bruce Stroever
  • Independent Director
  • 86.68K
  • Siddhesh R. Angle
  • Independent Director
  • 86.68K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg